While much work has concentrated on deriving scaling factors and optimising the metabolic stability techniques for consistency and rigour it is only relatively recently that the importance of binding to microsomes and hepatocytes has been appreciated. Ultrafiltration is often used to estimate binding to plasma proteins and microsomes but the level of nonspecific binding (NSB) to the ultrafiltration apparatus has not been adequately described. We derive an equation to correct for NSB and demonstrate that this can significantly affect the estimate of binding to microsomes and improve the accuracy of scaling to in vivo clearance for a series of barbiturates.
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Introduction
In early drug research projects much emphasis is placed on being able to predict the human pharmacokinetics to help identify candidate drugs with appropriate characteristics. One of the key parameters to estimate is that of metabolic clearance. Generally this is achieved either via extrapolation using allometry (Lavé et al. 1999) or through translating an understanding of scaling from metabolic stability in pre-clinical species liver microsomes and hepatocytes to those in human (Carlile et al 1997 , Riley et al 2005 . In the latter case, there has often been the assumption that the concentration added to the microsome or hepatocyte incubation is the same as the unbound concentration in the incubation. More recently it has been shown that non-specific binding (NSB) to microsomes and hepatocytes can be significant and hence the unbound concentration is lower than the total concentration added, often resulting in a dramatic effect on the estimate of clearance (Obach 1999 , McLure et al. 2000 , Austin et al. 2002 , Hallifax and Houston 2006 . Consequently it is important to estimate NSB in these in vitro incubations where a variety of models have been used including equilibrium dialysis and ultrafiltration. Although equilibrium dialysis is perhaps considered the gold standard technique, a literature search on publications involving protein binding since 2000 suggests that both equilibrium dialysis and ultrafiltration are utilised to similar extents.
Ultrafiltration has commonly been used to estimate the percentage unbound in both plasma and microsomes, predominantly due to the rapidity of the technique. However, the technique assumes that there is no NSB to the ultrafiltration apparatus as this could substantially alter the estimate. While Dow suggested that if NSB using ultrafiltration exceeded 5% another to the Centrifree tube sample reservoir and collection cup was determined by addition of barbiturates in protein free phosphate buffer (0.5 ml, 0.1 M, pH 7.4 in triplicate) directly to the reservoir and cup, with samples (0.2 ml) taken after 20 min. Phosphate buffer (1.0 ml, 0.07 M, pH 5.4) was added to the buffer solutions from the sample reservoir, collection cup and ultrafiltrate with 10l of phenobarbital (1.0mg/ml) added as an internal standard which were then extracted with MTBE (5 mL), the supernatant aspirated, evaporated to dryness under nitrogen at 40C, the residue reconstituted in methanol:water (0.2 mL, 50:50 v/v) and analysed by HPLC-UV. Aliquots (50 L) of all barbiturates were simultaneously analysed using a Hypersil ODS 5 micron (250 x 4.6 mm I.D.) column with a linear gradient operating of acetonitrile:water:trifluroacetic acid (15:85:0.1 to 90:10:0.1 v/v/v) at 1.0 ml/min, and the eluent monitored at 214 nm.
Stability in rat liver microsomes. The barbiturates were incubated individually (each at 100 nmol/ml, containing less than 3% acetonitrile) with microsomal protein concentrations (0.2 to 1.5 mg/ml) for up to 1 h at 37C to determine the metabolic linearity with time and protein concentration. NADPH was added immediately prior to incubation (at a final concentration of 2 mM) to each incubation. Intrinsic clearance was determined using Equation 2 with the AUC calculated at a range of microsomal protein concentrations as detailed in Table 4 .
Aliquots of microsomal suspensions were removed from the incubations and added to an equal volume of methanol. The mixtures were vortexed for a few seconds, centrifuged (approximately 1000 G for 5 min) and an aliquot of the supernatant analysed by direct injection using HPLC-UV using the method describe above. Barbituric acid concentrations were estimated by reference to the parent peak height in unincubated (control) samples. 
Equations
The fraction unbound (fu), correcting for non-specific binding to the ultrafiltration apparatus under non-saturating conditions is described by Equation 1 (see Supplemental data for derivation):
( 1) where fu mem , fu c and fu R are the fraction not bound to the membrane, collection cup and sample reservoir, respectively and fu o is the observed ratio Cu c /C mic with Cu c the measured concentration in the collection cup after filtration. For the experiments described in this paper, fu = fu mic , where fu mic is the fraction unbound in microsomes.
Intrinsic clearance was estimated from substrate disappearance in the linearity experiments in an analogous manner to pharmacokinetic analysis (Houston, 1994; Houston and Carlile, 1997; Lavé, et al., 1997) : (2) where Dose is the amount of barbiturate incubated and AUC the total area under the the terminal phase of the log concentration-time curve, determined by log-linear regression of the last few data points).
Intrinsic clearance was then scaled to quantify the full activity of the liver as measured in vitro using the methodology described by Houston (1994) . 
Results
A set of barbituric acid derivatives were chosen to cover a range of plasma protein binding (fu ranges from 0.51 to 0.0093) to investigate non-specific binding to Centrifree ultrafiltration tubes and the effect of non-specific binding to microsomes and the consequent effect on scaling to in vivo clearance. In protein-free buffer the total non-specific binding to the Centrifree tubes ranged from 2.8 to 54.5% for the n-pentyl to n-nonyl barbituric acids respectively ( Table 2 ). The high non-specific binding of the n-octyl and n-nonyl homologues is largely attributed to binding to the membrane (16.4 and 33.2% respectively), with a lower proportion binding to the reservoir and collection cup. In a separate experiment, the binding of the n-nonyl analogue was also determined at 25 and 100 nmol/ml where total binding and (cup).
The microsomal binding of n-pentyl to n-nonyl homologues (fu mic ) was calculated using Equation 1. Except for the n-pentyl homologue, which was largely unbound to microsomes, fu mic decreased with increasing protein concentration (Table 3) . For example, fu mic of the nnonyl homologue decreased from 0.45 to 0.18 for microsomal concentrations of 0.2 and 1 mg/ml, respectively. If the correction for non-specific binding to the apparatus were not applied, the fu mic values for the n-nonyl homologue would be 0.21, 0.14 and 0.09 for microsomal concentrations of 0.2, 0.5 and 1.0 mg/ml respectively.
The intrinsic clearances of the barbiturates determined in rat liver microsomes were scaled to predicted in vivo blood clearances using Equation 3 as shown in Table 4 
Discussion.
To accurately predict in vivo clearance from in vitro incubations, one of the initial assumptions often used is that the drug concentrations added to the incubation can be considered as essentially unbound and free to interact with metabolic enzymes. However, more recently the importance of binding to microsomal proteins has been shown to effect the unbound concentration and consequently the in vivo clearance prediction. Ultrafiltration is commonly used to determine protein binding although the aspect of NSB to the various components of the apparatus is often not fully considered and may appreciably alter the The assumption made in Equation 1 is that the system is operating under non-saturating conditions. This was found to apply to the most hydrophobic and highly bound analogue, the n-nonyl barbituric acid, for which the total binding and binding to the collection cap were found to be essentially the same for a four-fold change in concentration (25 to 100 nmol/ml).
Accordingly, it is reasonable to assume that non-saturating conditions also apply to the other analogues.
This article has not been copyedited and formatted. The final version may differ from this version. (2006) refined the model to a non-linear approach, which was more accurate than the Austin model for calculating fu mic for the n-pentyl to n-heptyl barbituric acids (fu mic /fu inc ratios of between 0.9 and 1.2), but tended to underestimate the binding of the more lipophilic n-octyl and nnonyl homologues (fu mic /fu inc ratios of between 0.5 and 0.6).
The importance of microsomal binding when scaling in vitro data to predict in vivo clearance was apparent in the current study. If fu mic had not been determined and was assumed to be 1, the calculated CL h,b values for the n-octyl and n-nonyl homologues, from substrate disappearance, would have underpredicted the in vivo values by 63 and 60% compared to an accuracy of 13 and 3% respectively when including binding. Also, fu mic varies with protein concentration and consequently this factor may help to account for any differences that may exist between metabolic rates at different protein concentrations.
Conclusion.
For compounds that bind non-specifically to the various components of the ultrafiltration device, the protein binding value that ignores this binding can be misleading and a correction DMD #40683 Table 2 Binding of barbituric acid homologues (mean %,  SE, n = 3) to the Centrifree ultrafiltration sample reservoir, membrane, collection cup and in total from protein-free media.
n-pentyl n-hexyl n-heptyl n-octyl n-nonyl Table 3 Calculated unbound fraction of barbiturates in rat microsomal preparations (mean fu mic ,  SE, n = 3). 
